Top compounds associated with response to BBS1


Feature Type Standardized
Nominal ANOVA
mRNA parbendazole CTRPv2 pan-cancer AAC -0.062 0.05
mRNA prima-1 CTRPv2 pan-cancer AAC 0.063 0.05
mRNA sirolimus:bortezomib (250:1 mol/mol) CTRPv2 pan-cancer AAC -0.067 0.05
mRNA Merck60 CTRPv2 pan-cancer AAC -0.06 0.05
mRNA BRD-K64610608 CTRPv2 pan-cancer AAC 0.077 0.05
mRNA nelarabine CTRPv2 pan-cancer AAC 0.076 0.05
mRNA ML050 CTRPv2 pan-cancer AAC 0.074 0.05
mRNA BRD9876:MK-1775 (4:1 mol/mol) CTRPv2 pan-cancer AAC -0.24 0.05
mRNA AZD1480 CTRPv2 pan-cancer AAC 0.1 0.06
mRNA LRRK2-IN-1 CTRPv2 pan-cancer AAC 0.072 0.06
Download CSV